The serialization of pharmaceutical products in the MENA countries is becoming increasingly relevant. More and more countries are introducing their own legislation. The term MENA stands for Middle East and North Africa. Countries included are Algeria, Bahrain, Egypt, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Libya, Malta, Morocco, Oman, Palestine, Saudi Arabia, Syria, Tunisia, and the […]
The pharmaceutical industry is constantly changing. We see the development of new drugs, regular regulation updates, introductions of additional countries specific serialization requirements, and artificial intelligence is also becoming increasingly important. In such a fast-moving market, it is not easy to maintain a constant overview. In particular, small and medium-sized companies often cannot keep track […]
Read More… from More Efficiency – Serialization in the Pharma Industry
Quality assurance managers in pharmaceutical companies play an essential role. As an intersection between the various departments, they make a crucial contribution to the smooth running of the company. In addition to monitoring production processes, actual quality management, and many other tasks, serialization management is thus sometimes treated somewhat neglectfully. The reasons for this are […]
Read More… from Business Partner Management: Pharma Serialization
In Canada, the next step for pharma serialization is planned for the end of 2023. In doing so, the country aims to improve tracking along the supply chain as well as patient safety. The North American country is thus pursuing the goal of providing all pharmaceuticals with a GS1 DataMatrix at the primary and secondary […]
Chestny ZNAK is the track andtrace system for the Russian market. Apart from pharmaceuticals, it ensures the security of the supply chain of many other goods. These goods include tobacco products, beer, medical devices, and food supplements. Counterfeit protection is expanding to fields other than pharmaceuticals, as Russia’s markets are particularly affected by counterfeiting. According […]
As of February 2023, EMVO’s AMS portal has been available to pharmaceutical companies for processing their alerts. With many functions, a clear presentation, and active user management, it makes the processing of error messages much easier. Since the EU-FMD came into force, alerts have also been a concern for pharmaceutical manufacturers. Recently, there have been […]
November 2023 marks an important date for the US pharmaceutical industry. The final phase of the DSCSA requirements revolves around interoperability and increased supply chain assurance. Verification Router Services (VRS) are one building block to meet the requirements. The DSCSA requires that all trading partners have a secure, electronic, and interoperable system in place for […]
Read More… from Understanding VRS: The 2023 DSCSA requirements
Pharmaceutical companies in need of a serialization provider are well-advised not to choose one arbitrarily. As an integral part of compliance and possibly years of collaboration, it is important to have a partner with whom you are fully satisfied. This is because, as in any industry, there are quite a few differences between providers. In […]
Read More… from 5 Tips for Choosing a Serialization Provider
In the European Union, medicinal products and medical devices are only approved for the market if manufacturers can guarantee the safety of their products. If adverse events occur after the products have been placed on the market, the vigilance procedures of the respective industries take effect. This is because patient safety continues to be a […]
Despite comprehensive preclinical and clinical studies, it is not uncommon for drug risks to be discovered only after market approval. Possible reasons are a larger patient population, multi-medication, off-label use, or medication errors. The pharmacovigilance department has the important task of identifying, assessing, better understanding and, if necessary, reporting these risks. In this way, a […]